Idiopathic Hypersomnia clinical trials at UCSF

1 research study open to eligible people

Idiopathic hypersomnia causes excessive sleepiness during the day without a known reason. UCSF is studying a new drug called ALKS 2680 to test its safety and if it can reduce daytime tiredness. This clinical trial is recruiting people who have been diagnosed with idiopathic hypersomnia.

Showing trials for

  • ALKS 2680 in Subjects With Idiopathic Hypersomnia

    open to eligible people ages 18-70

    The purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets

    San Francisco, California and other locations

Last updated: